Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines-Reference-Cited by-同舟云学术

Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines

Published:1987-03 Issue:1 Volume:5 Page:60-64
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pay T.W.F.,Hingley P.J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference17 articles.

1. A study of the physical properties of the immunising antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure;Wild;Arch. Ges. Virusforsch.,1968

2. Stability and immunogenicity of empty particles of foot-and-mouth disease virus;Rweyemamu;Arch. Virol.,1979

3. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus;Doel;Arch. Virol.,1982

4. Some statistical and experimental design problems in the assessment of FMD vaccine potency;Pay;Dev. Biol. Stand.,1977

5. Report Meeting Res. Group Eur. Committee Control FMD;Pay,1983

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production and Functional Evaluation of Anti-Loxosceles Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D;Biomedicines;2022-12-28

2. Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination;Frontiers in Veterinary Science;2022-12-01

3. Diversity of SAT2 foot-and-mouth disease virus in Sudan: implication for diagnosis and control;Veterinary Research Communications;2022-03-01

4. Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization;Journal of Virology;2021-11-23

5. Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines;Expert Review of Vaccines;2021-09-22